<?xml version="1.0" encoding="UTF-8"?>
<p>In the case of Gram-negative strains, the antibiotic amikacin (30Âµg disc) showed inhibition activity against 
 <italic>S. typhimurium</italic> (20 mm) and 
 <italic>A. baumannii</italic> (CRE) (15 mm), while 
 <italic>S. sonnei</italic> was observed to be resistant. All strains were not affected by dimethyl sulfoxide (DMSO), which was used as a negative control (
 <xref rid="molecules-26-00959-t003" ref-type="table">Table 3</xref>). The antimicrobial activity of carvacrol has been reported similarly by others against 
 <italic>E. faecalis</italic> [
 <xref rid="B48-molecules-26-00959" ref-type="bibr">48</xref>], 
 <italic>S. typhimurium</italic> [
 <xref rid="B49-molecules-26-00959" ref-type="bibr">49</xref>], and 
 <italic>A. baumannii</italic> indicating its potential effects in infectious disease control; antibacterial and antibiofilm activity against 
 <italic>Salmonella enterica</italic> serotype; antimicrobial activity of essential oils-derived volatile compounds against several nosocomial pathogens including representative multidrug-resistant 
 <italic>A. baumannii</italic> clinical isolates [
 <xref rid="B9-molecules-26-00959" ref-type="bibr">9</xref>].
</p>
